The company is collecting samples from people with their consent to create a database of genetic information
Hyper-personalised & data driven wellness platform, Answer Genomics has raised $500K in a pre-series A Round from Inflection Point Ventures. The funds will be utilised for supporting sales & marketing efforts and expanding the talent pool through strategic hiring initiatives. Additionally, these investments will enable Answer Genomics to continue advances in genomics and enhancing the well-being of individuals through personalised health insights by sequencing 10K genomes in the next 12 months.
Answer Genomics is a data driven precision health company dedicated to harnessing the power of multi-ominc data to assist individuals in making informed decisions about their health. Their approach involves delving directly into the genetic blueprint, microbiome and physiological parameters decoding both physical and mental health factors.
The company is collecting samples from people with their consent to create a database of genetic information. They take a small amount of blood and analyse more than 5 million data points from it. This helps them give personalised advice for staying healthy. They look at various parameters including genes, medical history, microbiome, and lifestyle to give you advice on how to be healthy now and in the future. Based on the data collected, they give advice suggesting food habits, lifestyle choices, supplements, and medications.
Rahul Ranganathan, CEO, Answer Genomics, says, “The advent of AI is changing the landscape of healthcare. We now possess the technology capable of understanding the human body for the masterpiece that it is. Multi-omnic data collected over a course of time forms a picture of current and future health allowing accurate prognosis, early diagnosis, and precision treatment. We believe precision health would reduce the burden on our healthcare infrastructure by allowing for accurate predictions, remote interventions, and faster recoveries.”